First National Advisers’s Edwards Lifesciences EW Stock Holding History

First National Advisers's EW Position: Q2 2026 in Review

First National Advisers increased its Edwards Lifesciences (EW) stake by 5.1% in Q2 2026, buying an estimated $154K and bringing the position to 37,854 shares worth $3.42M. The position accounts for 0.48% of the portfolio, ranked #54.

First National Advisers first reported a position in EW in Q2 2022 and has held it in 17 quarters since. The position peaked at $3.64M in Q2 2024. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

• First National Advisers held 37,854 shares of Edwards Lifesciences worth $3.42M as of Q2 2026.
• First National Advisers bought 1,842 Edwards Lifesciences shares in Q2 2026, an estimated $154K.
• Edwards Lifesciences made up 0.48% of First National Advisers's portfolio in Q2 2026, its #54 holding.
• First National Advisers first reported a position in Edwards Lifesciences in Q2 2022 and has held it in 17 quarters since.
• First National Advisers's Edwards Lifesciences position peaked at $3.64M in Q2 2024.
• 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on First National Advisers's 13F filing for Q2 2026, filed 21 Jul 2026.